港股异动 | 维升药业-B(02561)再涨超12% 隆培促生长素即将获批公司近期与东富龙达成战略合作

智通财经2025-12-02

智通财经APP获悉，维升药业-B(02561)再涨超12%，截至发稿，涨7.11%，报35.26港元，成交额190.82万港元。消息面上，安科生物近期披露合作进展，与维升药业合作的隆培促生长素即将获批。据悉，7月14日，安科生物宣布，公司与维升药业签订战略合作框架协议，共同推动隆培促生长素在中国市场的普及。值得注意的是，11月6日，第八届进博会期间，维升药业与国内制药装备龙头企业东富龙达成双腔冻干...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2588965083?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-12-02 11:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2588965083","market":"sh","top_or_hot":-1,"title":"港股异动 | 维升药业-B(02561)再涨超12% 隆培促生长素即将获批 公司近期与东富龙达成战略合作","media":"智通财经","content":"<div>\n<p>智通财经APP获悉，维升药业-B(02561)再涨超12%，截至发稿，涨7.11%，报35.26港元，成交额190.82万港元。消息面上，安科生物近期披露合作进展，与维升药业合作的隆培促生长素即将获批。据悉，7月14日，安科生物宣布，公司与维升药业签订战略合作框架协议，共同推动隆培促生长素在中国市场的普及。值得注意的是，11月6日，第八届进博会期间，维升药业与国内制药装备龙头企业东富龙达成双腔冻干...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1376389.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股异动 | 维升药业-B(02561)再涨超12% 隆培促生长素即将获批 公司近期与东富龙达成战略合作</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股异动 | 维升药业-B(02561)再涨超12% 隆培促生长素即将获批 公司近期与东富龙达成战略合作\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-12-02 11:04 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1376389.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，维升药业-B(02561)再涨超12%，截至发稿，涨7.11%，报35.26港元，成交额190.82万港元。消息面上，安科生物近期披露合作进展，与维升药业合作的隆培促生长素即将获批。据悉，7月14日，安科生物宣布，公司与维升药业签订战略合作框架协议，共同推动隆培促生长素在中国市场的普及。值得注意的是，11月6日，第八届进博会期间，维升药业与国内制药装备龙头企业东富龙达成双腔冻干...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1376389.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02561","symbol_name":"维昇药业-B","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1376389.html","article_id":"2588965083","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2588965083","pubTimestamp":1764644686,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP获悉，维升药业-B(02561)再涨超12%，截至发稿，涨7.11%，报35.26港元，成交额190.82万港元。消息面上，安科生物近期披露合作进展，与维升药业合作的隆培促生长素即将获批。据悉，7月14日，安科生物宣布，公司与维升药业签订战略合作框架协议，共同推动隆培促生长素在中国市场的普及。值得注意的是，11月6日，第八届进博会期间，维升药业与国内制药装备龙头企业东富龙达成双腔冻干制剂技术战略合作，并与临港新片区管委会、临港集团物贸平台签署产业协同协议，标志着其在“全球创新、中国加速”的战略实践进一步落地。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"300171":"东富龙","02561":"维昇药业-B","BK1161":"生物科技","BK0251":"专用设备"},"translate_title":"Changes in Hong Kong stocks | Weisheng Pharmaceutical-B (02561) rose by more than 12% again. Longpei somatotropin is about to be approved. The company has recently reached a strategic cooperation with Tofflon","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300171":1.5,"02561":1.5},"content_text":"智通财经APP获悉，维升药业-B(02561)再涨超12%，截至发稿，涨7.11%，报35.26港元，成交额190.82万港元。消息面上，安科生物近期披露合作进展，与维升药业合作的隆培促生长素即将获批。据悉，7月14日，安科生物宣布，公司与维升药业签订战略合作框架协议，共同推动隆培促生长素在中国市场的普及。值得注意的是，11月6日，第八届进博会期间，维升药业与国内制药装备龙头企业东富龙达成双腔冻干制剂技术战略合作，并与临港新片区管委会、临港集团物贸平台签署产业协同协议，标志着其在“全球创新、中国加速”的战略实践进一步落地。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation,productRelease","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2588965083","isCrawlerRequest":true}

港股异动 | 维升药业-B(02561)再涨超12% 隆培促生长素即将获批 公司近期与东富龙达成战略合作

精彩评论

港股异动 | 维升药业-B(02561)再涨超12% 隆培促生长素即将获批公司近期与东富龙达成战略合作